02.03.2023

Sales of over-the-counter (OTC) drugs reached RON6.7 billion (almost EUR1.4 billion) in 2022, up 23% from the previous year, data from market research company Cegedim show. more

08.17.2020

Pharmaceutical company Biofarm Bucuresti (BIO.RO) posted 29.8 million lei net profit in the first half, 6% higher than in the year-ago period, while revenue stood at RON106 million, up from the RON97 more

09.25.2018

more

08.21.2018

more

05.15.2018

Sales of over-the-counter (OTC) medicines topped RON880 million in Romania in the first quarter, up 13% on the year, the local producers association said Tuesday citing Cegedim data. more

12.02.2016

Reckitt Benckiser, the company that owns the Nurofen brand, Terapia and Biofarm, both of which with local manufacturing operations, account for 20% of the over-the-counter drug market, which means 480 more

10.25.2016

The best-selling over the counter (OTC) drugs in Romania are Nurofen of Reckitt Benckiser, followed by Aspenter (Terapia Cluj), Parasinus (GlaxoSmithKline) and No-Spa (Sanofi), according to the data more

10.18.2016

Sales of over-the-counter drugs in Romania went up from 600 million lei (EUR133 million) in 2004 to RON2.4 billion in July 2015 – June 2016, according to market research company Cegedim. This is one more

09.23.2016

Pharmaceutical drug manufacturer Terapia Cluj, a member of the Indian pharmaceutical group Sun Pharma, has boosted share of over-the-counter drugs to 50% of its product portfolio, double as much as in more

09.22.2015

Sales of over-the-counter (non-prescription) drugs stood at EUR673 million in Romania last year and accounted for 12.7% of the sales in the region, according to ZF’s calculations based on the data more

04.27.2015

The five largest pharmaceutical producers in Romania posted slight growth of merely 2% to 2 billion lei (EUR453 million) on a market that increased by almost 7% in 2014 and are bracing themselves for more

02.03.2015

The non-prescription drug (OTC) market rose by over 10% last year, but the average annual growth pace will go down to 4-5% as people’s incomes are not expected to register significant increases, more

04.16.2014

Terapia Ranbaxy, the largest pharmaceutical producer in Romania, posted 109 million lei (EUR24.4 million) net profit last year, up nearly 13% from 2012, and a 20% profit margin. Revenue overshot the more

04.04.2014

Over-the-counter drugs are set to be the fastest moving segment of the pharmaceutical market in the coming years, when they will rise at a clip of 8%, above the pace of the overall market, according more

01.23.2014

Sanofi, the largest pharmaceutical company in Romania, which owns the Zentiva plant (SCD.RO) in Bucharest, estimates exports could reach 30% of its production volume in 2013, double the 2012 level. more

07.29.2013

Romania’s energy exchange OPCOM plans to launch an over-the-counter (OTC) real time trading platform as of January 2014, the head of the Romanian Association of Electricity Suppliers said Monday. more

06.07.2012

Cluj-based pharmaceuticals producer Terapia Ranbaxy, a unit of Japan's Daiichi Sankyo, expects sales on the domestic market to reach about 400 million lei (EUR90 million) this year, up 14% from RON350 more

05.08.2012

Businessman Mihai Miron, who controls pharmaceutical company Ropharma, says he plans to have production growth outstrip total turnover growth this year. This is the first time Mihai Miron has ever more